Inspire Medical Systems Inc.
INSP | NYSE
$75.72
-$1.06 (-1.38%)
At close: Sep 21, 2026, 4:00 PM ET
$75.70
-$0.02 (-0.03%)
After-hours:
Sep 21, 2026, 7:13 PM ET
Market Data
Market Cap $2.22B
Enterprise Value $1.9B
Beta 0.70
Average Volume 996.98K
Shares Outstanding (Diluted) 28.94M
Shares Change YoY -1.92%
Institutional Ownership N/A
Exchange NYSE
ISIN US4577301090
Price Performance
Price Change 1M 23.2%
Price Change 3M 81.4%
Price Change 6M 47.3%
Price Change YTD -17.9%
Price Change 1Y -3.6%
Price Change 3Y -59.1%
Price Change 5Y -69.3%
1M CAGR (ann.) 30.4%
1Y CAGR (ann.) -4.0%
5Y CAGR (ann.) -20.2%
All-Time CAGR 14.3%
Valuation
PE Ratio 16.39
Forward PE 47.98
PEG Ratio 0.10
Forward PEG 0.71
PS Ratio 2.44
Forward PS 2.50
PB Ratio 2.65
P/FCF Ratio 18.70
P/Adj. FCF Ratio -937.11
P/OCF Ratio 13.89
EV/Sales 2.11
EV/EBIT 28.80
EV/EBITDA 24.17
EV/FCF 16.21
Earnings Yield 6.1%
FCF Yield 5.3%
Adj. FCF Yield -0.1%
Financial Health
Net Cash $320.68M
Total Debt $29.09M
Cash & Short-Term Investments $320.68M
Total Assets $925.99M
Current Ratio 8.55
Quick Ratio 6.16
Debt / Equity Ratio 0.04
Debt / EBITDA 0.37
Debt / FCF 0.25
OCF / Debt 5.40
Interest Coverage 406.94
Altman Z-Score 14.93
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 86.1%
Operating Profit Margin 6.0%
EBITDA Margin 9.3%
Net Profit Margin 15.0%
FCF Margin 13.0%
Adj. FCF Margin -0.3%
SBC / Revenue 13.3%
SBC Impact (per share) -102.0%
Returns
Return on Assets 14.6%
Return on Equity 17.6%
Return on Invested Capital 6.3%
Return on Capital Employed 6.3%
Return on Tangible Assets 14.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 19.5%
Revenue CAGR 5Y 38.7%
Revenue CAGR 10Y 60.6%
EPS CAGR 3Y 102.0%
EPS CAGR 5Y 224.6%
EPS CAGR 10Y 98.3%
FCF CAGR 3Y 83.5%
FCF CAGR 5Y 91.4%
FCF CAGR 10Y 2959.1%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 27
EPS Growth Next 3Y -19.4%
Revenue Growth Next 3Y 5.8%
Earnings Date Nov 1, 2026
EPS Estimate (next Q) $0.11
EPS Growth Est (next Q) -71.0%
Revenue Est (next Q) $204.16M
Revenue Growth Est (next Q) -9.1%
Fair Value Estimates
Graham Number $54.55
Graham Upside -28.0%
Lynch Fair Value $115.50
Lynch Upside 52.5%
Price Target $60.80
Price Target Upside -19.7%
Cash Flow
Operating Cash Flow $157.07M
Free Cash Flow $117.09M
Adj. Free Cash Flow $-2.34M
FCF Per Share $4.06
OCF Per Share $5.45
OCF/S Ratio 17.5%
Income Statement
Revenue $898.74M
Gross Profit $774.11M
Operating Income $54.12M
EBITDA $78.5M
Net Income $135.04M
EPS (Diluted) $4.62
Revenue / Employee $674.23K
Profit / Employee $101.31K
Employees 1,333
Add to Watchlist
Select watchlists to add or remove INSP